XORTX Therapeutics Statistics
Total Valuation
XRTX has a market cap or net worth of $4.23 million. The enterprise value is $1.71 million.
Important Dates
The next estimated earnings date is Friday, May 16, 2025, before market open.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XRTX has 3.79 million shares outstanding. The number of shares has increased by 45.25% in one year.
| Current Share Class | 3.79M |
| Shares Outstanding | 3.79M |
| Shares Change (YoY) | +45.25% |
| Shares Change (QoQ) | +12.82% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.27 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.53, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.53 |
| Quick Ratio | 3.29 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -83.06% and return on invested capital (ROIC) is -40.74%.
| Return on Equity (ROE) | -83.06% |
| Return on Assets (ROA) | -34.21% |
| Return on Invested Capital (ROIC) | -40.74% |
| Return on Capital Employed (ROCE) | -78.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.10M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.67% in the last 52 weeks. The beta is 0.17, so XRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -63.67% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 62.85 |
| Average Volume (20 Days) | 38,134 |
Short Selling Information
The latest short interest is 34,099, so 0.90% of the outstanding shares have been sold short.
| Short Interest | 34,099 |
| Short Previous Month | 24,840 |
| Short % of Shares Out | 0.90% |
| Short % of Float | 1.03% |
| Short Ratio (days to cover) | 1.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.62M |
| Pretax Income | -3.34M |
| Net Income | -3.31M |
| EBITDA | -2.58M |
| EBIT | -2.62M |
| Earnings Per Share (EPS) | -$1.15 |
Full Income StatementBalance Sheet
The company has $2.47 million in cash and $38,785 in debt, giving a net cash position of $2.43 million or $0.64 per share.
| Cash & Cash Equivalents | 2.47M |
| Total Debt | 38,785 |
| Net Cash | 2.43M |
| Net Cash Per Share | $0.64 |
| Equity (Book Value) | 3.34M |
| Book Value Per Share | 0.96 |
| Working Capital | 1.92M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.68M |
| FCF Per Share | -$0.97 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |